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Polyphenol rich oil palm leaves extract reduce hyperglycaemia and 
lipid oxidation in STZ-rats
Abstract: Diabetes mellitus is a degenerative disease affecting about 25% of people over 40 years and is a 
risk factor for cardiovascular disease. The oil palm (Elaies guineensis) leaf is a major waste of the palm oil 
industry, which is among the top vegetable oil industry in the world.   This study aims to evaluate the potential 
anti-diabetic effects of Oil palm leaves (OPL) ethanolic extract on normal and streptozotocin (STZ)-induced 
hyperglycaemic rats.  OPL were administered orally at 50, 100 and 200mg per kg body weight/day) to Sprague 
Dawley rats and monitored for its glycaemic, lipidemic and antioxidant modulating effects. The Oil palm leaves 
(OPL) ethanolic extract treatment dose-dependently reduced blood glucose and oxidation in the STZ rats, and 
restored antioxidants enzymes levels. The optimum dose was 100mg/kg, which effectively reduced liver and 
kidney damage to the level of normal rats. This is the first study on dietary OPL ethanolic extract ability to 
modulate physiological responses and show organ protective effects against tissue damage in STZ-induced 
chronic hyperglycaemic rats.  At the doses used OPL showed no adverse or chronic toxicity effects in these rats, 
indicating its potential use as a new functional food ingredient.
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Introduction
Plants represent a good source of potentially useful 
dietary supplements for improving blood glucose 
control and preventing long- term complications 
in diabetics (Gallagher et al., 2003). The main 
characteristics of diabetes are hyperglycaemia, 
polyuria, polydipsia and polyphagia, weight loss, 
muscle weakness and dyslipidemia.  Chronic 
hyperglycaemia is normally accompanied by 
increased risk to hypertension, oxidative stress, 
decreased fibrinolytic activity, increased platelet 
aggregation, and severe atherosclerosis (Reusch, 
2003). Many synthetic drugs have been developed 
for the treatment of hyperglycaemia but there is much 
interest in discovering cheaper, natural treatments 
without side effects that can reduce the risk of 
diabetes. 
The World Health Organization estimated that 
in 2010 diabetes will affect about one quarter billion 
people worldwide, mostly as non-insulin dependent 
diabetes mellitus (NIDDM). The number of diabetic 
patients has increased due to the increasing sedentary 
life style (Enoki et al., 2007). Treatment of diabetes by 
insulin and oral hypoglycemic drugs fails to prevent 
these complications in many patients, warranting 
additional research for effective alternative 
treatments. Recently, there are increasing interest 
for the development and utilization of antidiabetic 
plants, owing to their renewable resource and possible 
beneficial effects besides other economical reasons 
(Zhao et al., 2007). Knekt et al. (2002), proved in a 
clinical study that a reduction in risk of type 2 diabetes 
relate to higher quercetin, and myricetin intakes.  
Oil palm (Elaeis guineensis) is grown primarily 
in the tropics and represents the second-largest 
contributor to human vegetable oil consumption 
after soybean (Mielke, 1996).  The oil palm leaf 
is a major waste of this oil palm industry.  The Oil 
Palm leaves alcoholic extract (OPL) contains 24.3 
mg gallic acid equivalent (GAE)/g dry weight of 
non toxic, phenolic compounds (mainly common 
glycosylated flavonoids, catechins and carotenoids) 
which is higher than green tea (22.5 mg GAE/g dry 
weight) (Runnie et al., 2003).  The OPL effectively 
inhibited low density lipoprotein (LDL) oxidation 
better than other edible plant extracts (Salleh et al., 
2002).   There are currently very little documentations 
on oil palm leaf (OPL) therapeutic properties. The 
discovery of the good ex-vivo antioxidant properties 
of OPL forms the basis of this study, which is to 
evaluate its potential beneficial effects for chronic 
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hyperglycaemia (diabetics) where oxidative stress 
plays a major detrimental role. 
Materials and Methods
Extraction 
All analytical grades chemicals and drugs were 
obtained from Sigma-Aldrich (St.  Louis, MO). 
Ketamine and xylazine were from the Veterinary 
Hospital, Faculty of Veterinary Medicine, UPM. 
Pyrogallol and dithio-bis(2-nitrobenzoic acid) 
(DTNB) were from Merck (Malaysia).  
Oil palm (Elaeis guineensis) leaves obtained from 
the Universiti Putra Malaysia (UPM) plantation, were 
chopped and freeze-dried for 24-48hr. The dried leaves 
was ground to a powder, and extracted with absolute 
ethanol at a 1:10 (w/v) solvent ratio under continuous 
agitation for 24hr in the dark.  After filtration the 
residue was re- extracted twice.  The pooled extract 
was vacuum- dried in a rotary evaporator, at 40°C, 
until the solvent was completely removed to yield a 
dark green waxy material.  The extract was stored in 
glass vessels, flushed with nitrogen at -20°C.  
Animal study 
All experimental procedures and animal care 
had been approved by the Institutional Animal Care 
and Use Committee (IACUC), Faculty of Veterinary 
Medicine, Universiti Putra Malaysia, and care were 
taken to minimize pain or discomfort. Male Sprague- 
Dawley rats weighing 220-300g were housed in 
clean cages and kept in well ventilated room  with 
a 12 h light/ dark cycle at 22-25°C. The rats were 
maintained on a standard rat pellets (Gold Coin 
Sdn.  Bhd., Klang, Malaysia) and water provided ad 
libitum. Water was used as the vehicle for dissolving 
and dispensing OPL (50-200mg OPL /kg/day by oral 
gavage).  The vehicle was given to all rats similar to 
rats receiving OPL.
Preparation of diabetic rats 
Hyperglycaemia was induced in rats by a single 
intraperitoneal (i.p.) injection of 60mg streptozotocin 
/kg body weight (bw). Three days after injection, the 
rats with fasting blood glucose higher than 7.8mmol/L 
were considered hyperglycaemic/diabetic.  The rats 
were divided into seven groups (50 diabetic and 20 
normal rats); (i) NC: Normal control rats  (ii) N100-
OPL: Normal rats receiving 100mg/kg OPL (iii) 
DC: Diabetic control  rats (iv) D50-OPL: Diabetic 
rats receiving 50mg OPL (v) D100-OPL: Diabetic 
rats receiving 100mg OPL (vi) D200-OPL: Diabetic 
rats receiving 200mg OPL (vii) GB: Diabetic rats 
receiving glibenclamide (GB) orally (30mg/kg b.w.) 
in aqueous solution.  Feed and water were removed 
from cages 12 h before blood were collected from 
the rats’ tails for blood glucose (glucometer Accu-
chek sensor, Roche, USA) on the 1st day and every 3 
days.  Changes in body weights were recorded in the 
fasting state.  The animals were sacrificed after blood 
collection following euthanasia on the 35th day of 
the experiment.
Plasma and Red Blood Cells Preparation 
Two ml of blood was drawn via cardiac puncture 
from each rat under ketamine/xylazine (ketamine – 50 
mg/kg, xylazine 5 mg/kg) combination anaesthesia. 
The blood were collected  in heparinised tubes and 
kept on ice before being centrifuged at 3000xg for 10 
minutes to separate the red blood cells (RBC) from 
the plasma. The RBC was washed and centrifuged 
three times with 0.9% NaCl at 3000xg for 10 minutes, 
respectively. The RBC and plasma was kept at -80°C 
for further use. 
Biochemical and histopathological analysis
Total protein, triglyceride (TG), aspartate amino 
transferase (AST), alanine amino transfarase (ALT) 
levels in plasma were determined on Hitachi 902 
automated analyzer. The thiobarbituric acid reactive 
substances (TBARS) concentration, SOD and CAT 
were measured according to established methods 
(Zhang et al. 1997; Aebi, 1974; Marklund and 
Marklund, 1974 respectively). 
For histopathological analysis, liver and kidney 
tissue sections (5 μm) were deparaffinised and 
processed for routine hematoxylin-eosin (H&E) 
staining.  Ten randomly selected fields of each 
section were observed with a light microscope under 
100 x magnifications. The detailed quantitative 
histological observations were made on battlement 
(zigzag) manner on the least 20 fields per slide and 
the percentage of necrotic and inflamed cells of liver, 
abnormal hepatocytes or glomerulus and tubules 
were calculated.  
Data analysis 
The results were expressed as means ± SEM. 
The statistical analysis was carried out using one- 
way analysis (ANOVA) followed by Tukey test. All 
procedures were performed at 95% confidence level.
Results and Discussions
Blood glucose levels
The STZ increased the fasting blood glucose from 
5 mmol/L to more than 12 mmol/L within 3 days, 
and to about 22 mmol/L after 1 week.  Administration 
of OPL significantly (p < 0.05) attenuated this 
blood sugar increase dose dependently in STZ rats 
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(Figure 1). The OPL showed no hypoglycaemic or 
other apparent toxic effects in normoglycaemic rats. 
The blood sugar in all normoglycaemic rats were 
unchanged throughout the study, while all untreated 
STZ rats showed an increasing trend.  
Body weight changes
The untreated hyperglycaemic rats (DC) showed 
significant (p<0.05) weight loss by about 40% 
when compared to normal rats by the 35th day (Fig 
2.). Glibenclamide treatment to STZ rats did not 
significantly reduce this weight loss.  However, OPL 
significantly (p<0.05) prevented the weight loss in 
STZ rats, dose dependently, and caused significant 
weight gains in normal rats.  Based on the body 
weights, the apparent optimum dose is 100mg/kg 
body weight. 
During the course of the experiment, 20 rats died; 
6 from untreated STZ group, 4 from the D50-OPL 
group; 3from the GB group; and  1 each from the 
D100-OPL and D200 OPL groups.  The OPL treatment 
not only reduced weight loss but significantly reduced 
the mortality rate where at dose 100 and 200mg/kg 
showed very significant lower mortality compared 
to the untreated STZ group. At 100 and 200mg/kg 
bw, the mortality was improved by 71% compared 
untreated STZ group (DC). 
Oxidative stress status
The oxidative stress status, measured as TBARS 
were significantly lower in the plasma of OPL treated 
rats compared to the untreated DC rats. DC rats had 
250% more TBARS compared to NC and both the 
OPL and GB treatment normalised the TBARS levels 
(Table 1).  TBARS level were highest in DC rats and 
lowest (p<0.05) in the D100-OPL group, pointing 
to the OPL in-vivo antioxidative effects.  Chronic 
hyperglycaemia caused the endogenous antioxidant 
enzymes activities (erythrocyte SOD and catalase) 
to decrease.  The OPL treatment dose- independence 
restored the antioxidant enzymes activities to near 
normal levels in STZ rats (p<0.05)  (Table 1). 
Total protein and creatinine levels were 
significantly low in DC rats. STZ rats treated with 
OPL and GB significantly (p< 0.05) restored the 
serum total protein and creatinine to normal levels 
(Table 2). AST and ALT were significantly high in DC 
rats and both OPL and GB treatments significantly 
re-establish them to normal levels. Revival of serum 
total protein, AST, ALT and creatinine of diabetic rats 
towards normal levels indicated that the OPL produced 
no adverse effect on the liver and kidney functions. A 
significant decrease in serum triglycerides (TG) was 
observed in DC rats, while OPL treatments restored 
them to normal levels.  Table 3 shows the effect of 
OPL on the liver and kidneys of normal and diabetic 
rats.  In the liver, the changes caused after induction 
of diabetes are granular cytoplasm, dilated sinusoids, 
shrunken nuclei and inflammation, which was reduced 
after dietary supplementation with OPL. Table 3 also 
shows the protective effects of Elaies guineensis 
extract on diabetic rats liver and kidney through 
histopathological enumeration of the cells. The DC 
livers and kidneys showed major injury.   All rats in 
the diabetic groups exhibited similar pathological 
changes in the kidney. Lesions of the diabetic kidney in 
DC groups involved the glomeruli including capillary 
basement membrane thickening with expansion of 
the mesangium showed in Figure 3. These changes 
lead to initial hyperfiltration eventually leading to 
renal insufficiency or complete kidney failure. The 
percentage of abnormal cells in OPL treated STZ-
Figure 3. Photomicrograph of rat’s kidney from DC group at necropsy. An expansion of mesangium (A), loss of 
glomeruli (B) were observed as compared to kidney in OPL treated group (C) (H&E, X 200)
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TREATMENT Catalase (k/s/mg protein) SOD(U/ g protein) TBARS(µM/ g protein)
NC 0.006 ± 0.001b 1.971 ± 0.173bc 0.159 ± 0.034b
N100OPL 0.006 ± 0.001b 3.580 ± 1.300c 0.224 ± 0.038b
DC 0.002 ± 0.001a 0.211 ± 0.056a 0.405 ± 0.168c
GB 0.006 ± 0.001b 2.021 ± 0.537c 0.156 ± 0.020b
50mg OPL/kg 0.004 ± 0.000a 1.085 ± 0.247b 0.181 ± 0.060b
100mg OPL/kg 0.006 ± 0.000b 1.764 ± 0.268c 0.070 ± 0.004a
200mg OPL/kg 0.005 ± 0.002b 2.449 ± 0.456c 0.185 ± 0.049b
Table 1. The antioxidant markers of different groups of rats fed with Elaies guineensis leaf ethanolic extract.
SOD: Superoxide Dismutase;  TBARS: Thiobarbituric acid Reactive substances
(i) NC: Normal control rats  (ii) N100-OPL: Normal rats receiving 100mg/kg OPL   (iii) DC: Diabetic control  rats   (iv) D50-
OPL: Diabetic rats receiving 50mg OPL   (v) D100-OPL: Diabetic rats receiving 100mg OPL    (vi) D200-OPL: Diabetic 
rats receiving 200mg OPL    (vii) GB: Diabetic rats were receiving glibenclamide (GB) orally (30mg/kg b.w.) in aqueous 
solution.  Bar represent means ± SEM of ten rats for each group (n=10).
 
a-c, Mean with different letters within each row are significantly different (P<0.05).
TREATMENT
 
TG TOTAL PROTEIN AST ALT Creatinine
(mg/dl) (g/dl) (U/L) (U/L) (µmol/L)
NC 1.55 ± 0.09b 75.38 ± 0.59b 211.1± 8.5b 53.56  ±  3.75b 67.38 ± 2.05b
N100OPL 1.71 ± 0.08b 75.43 ± 0.69b 220.4 ± 16.8b 52.01 ± 2.63b 60.71 ± 2.26b
DC 0.59 ± 0.17a 62.50 ± 5.94a 439.1 ± 27.2a 129.8 ± 15.1a 57.33 ± 5.33a
GB 0.91 ± 0.17a 73.00 ± 0.58b 178.0 ± 7.71c 89.7 ± 12.1b 52.60 ± 2.29a
50mg/kg 2.02 ± 0.23b 77.50 ± 0.76b 228.4 ± 13.4b 78.34 ± 9.37b 64.50 ± 1.70b
100mg/kg 1.65 ± 0.49b 74.56 ± 1.49b 225.0 ± 13.3b 79.60 ± 7.69b 71.11 ± 4.48b
200mg/kg 2.34 ± 0.28b 71.88 ± 0.64b 261.6 ± 5.9b 64.85 ± 1.27b 63.13 ± 2.02b
Table 2. The effect of Elaies guineensis leaf ethanolic extract on liver and kidney markers
TG: TRIGLYCERIDES, AST: aspartate amino transferase, ALT: alanine amino transfarase 
(i) NC: Normal control rats  (ii) N100-OPL: Normal rats receiving 100mg/kg OPL   (iii) DC: Diabetic control  rats   (iv) D50-
OPL: Diabetic rats receiving 50mg OPL   (v) D100-OPL: Diabetic rats receiving 100mg OPL    (vi) D200-OPL: Diabetic rats 
receiving 200mg OPL    (vii) GB: Diabetic rats were receiving glibenclamide (GB) orally (30mg/kg b.w.) in aqueous solution.  
Data are expressed as means ± SEM (n= 10). p< 0.05, as compared to control diabetic. 
a-c, Mean with different letters within each row are significantly different (P<0.05).
Treatment Kidney damage (%) Liver necrotic & inflamed cells (%)
OPL 50mg/kg 31.7 ± 3.9a 24.40 ± 2.76a
OPL 100mg/kg 25.4 ± 3.1a 25.20 ± 1.94a
OPL 200mg/kg 40.1 ± 5.6a 34.73 ± 1.50a
NC 30.0± 4.8a 54.00 ± 2.08b
DC 80.2 ± 5.5c 88.00 ± 1.53c
Table 3. The protective effects of Elaies guineensis leaf extract on liver and kidney histopathology of diabetic rats
(i) NC: Normal control rats  (ii) N100-OPL: Normal rats receiving 100mg/kg OPL   (iii) DC: Diabetic 
control  rats   (iv) D50-OPL: Diabetic rats receiving 50mg OPL   (v) D100-OPL: Diabetic rats receiving 
100mg OPL    (vi) D200-OPL: Diabetic rats receiving 200mg OPL    (vii) GB: Diabetic rats were 
receiving glibenclamide (GB) orally (30mg/kg b.w.) in aqueous solution. 
Data are expressed as means ± SEM (n= 10). p< 0.05, as compared to control diabetic. 
a-c, Mean with different letters within each row are significantly different (P<0.05).
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Figure 1. Effects of Elaies guineensis leaf ethanolic extract on the Blood glucose levels  of different groups of rats at 
different time intervals. 
[(i) NC: Normal control rats  (ii) N100OPL: Normal rats receiving 100mg/kg OPL   (iii) DC: Diabetic control  rats   (iv) 
OPL50mg/kg: Diabetic rats receiving 50mg OPL   (v) OPL100mg/kg: Diabetic rats receiving 100mg OPL    (vi) OPL 200mg/kg: 
Diabetic rats receiving 200mg OPL    (vii) GB: Diabetic rats were receiving glibenclamide (GB) orally (30mg/kg b.w.) in aqueous 
solution]
  
Bar represent means ± SEM of ten rats for each group (n=10). p < 0.05 as compared to diabetic control.   
Figure 2. Effect of Elaies guineensis left ethanolic extract on body weight (g) changes in rats. 
[(i) NC: Normal control rats  (ii) N100OPL: Normal rats receiving 100mg/kg OPL   (iii) DC: Diabetic control  rats   (iv) 
OPL50mg/kg: Diabetic rats receiving 50mg OPL   (v) OPL100mg/kg: Diabetic rats receiving 100mg OPL    (vi) OPL 200mg/kg: 
Diabetic rats receiving 200mg OPL    (vii) GB: Diabetic rats were receiving glibenclamide (GB) orally (30mg/kg b.w.) in aqueous 
solution] 
 
Bar represent means ± SEM of ten rats for each group (n=10). p < 0.05 as compared to diabetic control.   
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rat livers and kidneys were insignificantly different 
to NC liver and kidney levels.  Few damages in the 
form of swelling of hepatocytes and vacuolation that 
were observed in OPL treated rats.  In normal rats 
no significant difference was found between NC 
rat and OPL treated rat for hepatocyte and nephron 
abnormalities.  
Streptozotocin- induced hyperglycaemia is a well- 
documented model of experimental diabetes. STZ 
was known to destroy insulin producing pancreatic 
cells. Low dose of STZ- diabetic induction rat model 
would appear to represent a good experimental 
NIDDM diabetic state and provides a relevant 
example of endogenous chronic oxidative stress due 
to the resulting hyperglycemia (Like and Rossini, 
1976). Induction of diabetes in the experimental 
rats was confirmed by the presence of a high fasting 
plasma glucose level. Diabetes induced by STZ is 
associated with the characteristic loss of body weight 
which is due to muscle wasting (Swanston-Flatt et 
al., 1990). Body weight and mortality improvements 
by OPL treatments in the study may be a reflection of 
the improved health of the diabetic groups. 
This is the first report of the good anti-
hyperglycaemic effects of OPL in STZ- induced 
diabetic rats. The OPL may possess diverse biological 
activities and pharmacological function, but currently 
there is no documentation of OPL’s glycaemic and 
lipidemic modulating properties. Leaves often contain 
substantial amounts of antioxidants, flavonoids and 
polyphenols and the present study suggests that 
antioxidant action may be an important property of 
OPL associated with the anti-hyperglycaemic effect. 
The majority of traditional antidiabetic plants await 
proper scientific and medical evaluation for their 
ability to improve blood glucose control (Gray and 
Flatt, 1997). In this study, the antioxidant and blood 
glucose lowering effects of OPL could be due to its 
flavonoids content. However not all flavonoids have 
anti-hyperglycaemic activities, depending on their 
phenolic structure. Some leaf extracts are toxic. A 
reduction in risk of type 2 diabetes was clinically 
proven to relate with higher quercetin, and myricetin 
intakes (Knekt et al., 2002).  Some flavonoids 
are known to help heal free radical- mediated 
diseases such as diabetes (Czinner et al., 2000). 
Flavone materials have various biological effects 
which includes immunomodulating, anti-oxidant, 
lipidaemic, blood vessel and glycaemic modulatingh 
properties (Hollman and Katan, 1999).  
Insulin-dependent diabetes mellitus cause 
chronic microvascular, macrovascular and 
neurologic complications resulting in morbidity and 
mortality (sudden death, death from hyperglycaemia 
or hypoglycaemia, fatal or non-fatal myocardial 
infarction, angina, heart failure, stroke, renal failure, 
peripheral vascular disease, amputation, vitreous 
haemorrhage, retinopathy, blindness, cataract 
extraction). Intensive treatments for maintaining 
blood glucose concentrations close to the normal 
range could decrease the frequency and severity of 
complications, such as development of retinopathy, 
microalbuminuria (high urinary albumin and 
neuropathy (Shamoon et al., 1993; Turner 1998). The 
chief adverse event associated with intensive therapy 
is severe hypoglycaemia.  The OPL were shown in 
this study to not cause hypoglycaemia.
The final products of lipid peroxidation can be 
evaluated by the TBARS levels (Requena et al., 1997). 
The balance between both the enzymatic and non- 
enzymatic antioxidant activities in the intracellular 
levels are important for the health and survival of 
organism (Grazioli et al., 1998). These enzymatic 
antioxidant defences include superoxide dismutase 
(SOD), gluthathione peroxidise (GPX), catalase 
(CAT), while the non enzymatic are ascorbic acid 
(vitamin C), α- tocopherol (vitamin E), gluthathione 
(GSH), β- carotene, and vitamin A (Stahl et al., 
1998).  
The roles of oxidative stress and antioxidants in 
organs and tissue damage have been reportedly widely 
in diabetics (West, 2000).  The diabetogenic action of 
STZ can be prevented by the SOD, CAT and other 
hydroxyl radical scavengers; suggesting that diabetes 
involves superoxide anion and hydroxyl radicals 
(Ames et al., 1993). In this study, STZ treatment 
significantly increased lipid peroxides and decreased 
antioxidant enzymes activities in the plasma of 
the rats, confirming that STZ- induced diabetes is 
accompanied by an increased generation of reactive 
species (Winiarska et al., 2006). Lipid peroxidation 
in STZ- induced diabetes was elevated from the 
reduction in the levels of reduced gluthathione, a 
potent endogenous antioxidant. 
The generation of reactive oxygen species 
(oxidative stress) play important roles in the etiology 
of diabetic complications. Many biochemical 
pathways strictly associated with hyperglycemia 
(namely glucose autoxidation, polyol pathway, 
prostanoid synthesis, protein glycation), subsequently 
increase free radicals production. Exposure of 
endothelial cells to prolonged hyperglycaemia leads 
to amplified production of superoxide anion, which 
may extinguish nitric oxide, a potent endothelium- 
derived vasodilator that participates in the general 
homeostasis of the vasculature, causing reduced 
endothelial-dependent relaxation and delayed cell 
replication (Giugliano et al., 1996).  These effects are 
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reversed by dietary antioxidants such as OPL. 
Radical-mediated damage to proteins may be 
initiated by autoxidation of lipids and sugars. The 
consequent protein oxidation reactive products 
include protein hydroperoxides. Oxidized proteins 
are frequently functionally useless and are more 
susceptible to proteinases. However, some oxidized 
proteins have damaging actions as observed in aging, 
diabetes, atherosclerosis and neurodegenerative 
diseases. Protein oxidation occasionally plays 
controlling roles in cellular remodelling and 
cell growth (Dean et al., 1997).  Thus dietary 
supplementation with antioxidants such as OPL help 
could prevent this oxidative damage to proteins.
Liver and kidney beneficial or toxic effects of the 
supplement were assessed through serum markers 
namely total protein, AST, ALT and creatinine. 
The serum AST and ALT activities in STZ-diabetic 
rats were significantly above normal, as previously 
reported (Greive et al., 2003), and OPL treatments to 
diabetic rats prevented this increases, indicating here, 
that OPL effectively inhibited diabetic nephropathy 
and hepatopathy. Diabetic nephropathy is measured 
by excess urinary albumin excretion and abnormal 
serum creatinine levels.  Measurement of the 
aminotransferases (ALT and AST) is of toxicological 
importance as changes in their activities are indicative 
of tissue damage by toxicants or in disease conditions 
(Singh et al., 2001). ALT and AST are intracellular 
hepatic enzymes that have leaked into the circulation 
and serve as a marker of hepatocyte injury. 
This study provides evidence of some antioxidative 
protective effect of OPL against extensive damages 
in the kidneys and liver under oxidative stress or 
hyperglycaemia.  The kidney exhibits a characteristic 
pattern of changes in the glomerulus during 
diabetes (Shafrir and Sima, 2000). These important 
hyperglycaemic target organs play important roles in 
regulating chronic hyperglycaemia.  Diabetes causes 
carbohydrate metabolism changes that adversely affect 
their functions.  Hyperglycaemia caused increase in 
fluid intake and increased water excretion, resulting 
in over burdening to the kidneys.  The possible 
beneficial or toxic effects of OPL can be monitored 
from the kidney function test. The creatinines were 
used as indices of changes in glomerular filtration 
rate. Significant elevations in plasma creatinine 
levels occur only when there are at least 75% non-
functional nephrons. Here, the creatinine levels were 
significantly lower in the DC and GB groups indicated 
increased fluid intake and excretion while OPL 
treated rats were in the normal ranges.  This together 
with the reduced number of abnormal glomerulus 
compared to the untreated DC group, illustrate the 
protective effect of OPL on the glomerulus.  The DC 
rats possessed many abnormal glomeruli signifying 
glomerulus damage, which includes some glomeruli 
loss and shrunken glomerulus.  The free radicals 
may alter the structure and function of the kidney, 
especially the glomerulus and cause diverse types of 
glomerular lesions pathophysiology, ranging from 
inflammatory to apoptosis.  All the livers and kidneys 
of OPL treated normal rats were normal without any 
observable injury indicating the non- toxic nature 
of OPL.  Hepatic fat accumulation which caused 
hepatocyte necrosis in the liver is a well- recognized 
complication of diabetes with reported frequency of 
40-70% (Levinthal et al., 1999). In STZ rats’ liver, 
vacuolation and a significant number of hepatocyte 
necrosis was observed whereas STZ+OPL rats 
liver were slightly better than normal.  The high 
antioxidant content of OPL may be associated to the 
organs protective effect. 
Flavonoids are synthesised from phenylalanine 
and generally affects various enzymes and gene 
expression. Flavonoids toxicity to animal cells is low, 
and are major functional components of many herbal 
preparations for medical use since ancient times. The 
daily intake of flavonoids with normal food, is about 
1-2 g (Havsteen, 2002) and this can be supplemented 
or increased by OPL consumption.
Conclusion
 
The results of this study strongly suggest that OPL 
is potentially useful for the alleviation of diabetic and 
secondary complications diabetics. It is well known 
that certain flavonoids exhibit hypoglycaemic activity 
and are able to help regenerate the beta cells of the 
pancreas. The significant antihyperglycaemic effect 
of OPL is probably due to it flavonoids contents. 
Further work is needed to investigate the actual active 
components in the OPL.  The present investigation 
reports the first anti-hyperglycaemic activity of OPL 
which may be a new potential alternative in the 
treatment and management of diabetes. 
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